EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Review Article: Tumor Markers, Types and Clinical Applications

RANA, Salah Mohammed Fezea, Jameelah Kadhim TAHER ALISAWI

Academic Science Journal · 11.06.2025 · 3 (2) · 79-92

DOI: 10.24237/asj.03.02.941c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Science Journal, online erschienen am 11.06.2025. Verfasst von RANA und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past ten years, tumor markers have played an increasingly important role in clinicaloncology. This trend is expected to continue as technology advances and our knowledge of thehuman body and disease processes grows. In the treatment of cancer, tumor markers are widelyused for a variety of purposes, including screening, selecting a management strategy,determining the prognosis, and post-therapy follow-up. A comprehensive of the fundamentalsof pathophysiology and identification strategies for each specific malignancy is necessary fortheir prudent application in clinical practice. Oncology's use of cancer biomarkers hastransformed the way that cancer is treated, and led to notable improvements in patient outcomesand cancer treatment.

Zitieren

APA

RANA, Fezea, S. M., & ALISAWI, J. K. T. (2025). Review Article: Tumor Markers, Types and Clinical Applications. Academic Science Journal, 3(2), 79-92. https://doi.org/10.24237/asj.03.02.941c

Vancouver

RANA, Fezea SM, ALISAWI JKT. Review Article: Tumor Markers, Types and Clinical Applications. Academic Science Journal. 2025;3(2):79-92. doi:10.24237/asj.03.02.941c

BibTeX
@article{RANA2025,
  author = {RANA and Fezea, Salah Mohammed and ALISAWI, Jameelah Kadhim TAHER},
  title = {Review Article: Tumor Markers, Types and Clinical Applications},
  journal = {Academic Science Journal},
  year = {2025},
  volume = {3},
  number = {2},
  pages = {79--92},
  doi = {10.24237/asj.03.02.941c}
}
Kostenlos starten →